After 11 years in pharma commercial operations and managed markets, I’ve learned one absolute truth: health system executives do not care about your product launch celebration. They care about financial risk, operational burden, and whether your drug will blow up their quality metrics. If you are still trying to access these decision-makers by asking for a "quick coffee chat," you are burning bridges before they are even built.
Getting in front of the people who actually influence health system formulary positioning is not a sales game. It is a logistics, evidence, and timing operation. Stop treating this like a prescriber reach exercise. It isn't.
The Fundamental Misunderstanding: Payer Strategy vs. Prescriber Reach
Most commercial teams fail because they treat health system executives like high-prescribing physicians. They lead with clinical efficacy. While important, clinical efficacy is the bare minimum requirement to get into the building. It is not the key to the boardroom.
Managed care strategy within a health system revolves around three pillars: Pricing, Affordability, and HTA Pressure. Executives are constantly being squeezed by rising drug costs versus fixed-payment models. When you approach them, you need to speak their language—the language of the CFO, not just the Chief Medical Officer.
If you aren't bringing data on total cost of care, medical necessity documentation requirements, and reimbursement pathways, you are wasting their time. Period.
Choose Your Arena: Where Executives Actually Live
Don't send cold emails to hospital C-suites. They have gatekeepers whose entire job is to delete your LinkedIn InMail. You need to be where they are, but you have to be there with a purpose, not just a badge.
1. The Health Management Academy (THMA)
THMA is the gold standard for executive forums in healthcare. The environment here is different. It’s not about clinical data; it’s about strategic partnerships. If you aren't engaging with their leadership cohorts, you’re missing the actual decision-making units. When you are here, don't pitch. Listen. Ask them about their biggest operational headaches regarding specialty drug utilization.
2. AMCP (Academy of Managed Care Pharmacy)
This is where the people who actually run the P&T committees go. The focus here is on the technical side of access. Use this time to test your evidence dossiers. If you are presenting at AMCP, make sure your data is robust enough to handle the scrutiny of a pharmacy director. If you cannot defend your value proposition here, you will never get on a formulary.
3. Association of Cancer Care Centers (ACCC)
If you are in the oncology space, ACCC is vital. These executives are obsessed with the "Buy and Bill" model and the impact of the Inflation Reduction Act on their margins. If your access execution plan doesn't account for the administrative burden of procurement and reimbursement for their cancer centers, your drug will be relegated to a "non-preferred" status regardless of how good the survival data looks.
Digital Tools and the Friction of Data
We live in an age of data overload, yet accessing clean information is still a nightmare. Think about the "Cookie Law Info" popups you see on websites—the ones that block your view, force you to click, and make you jump through hoops just to see what you came for. That is exactly what your current evidence generation process feels like to a health system executive.
You need to provide digital tools in evidence generation that remove friction. If your reimbursement support tool requires five logins pharmashots and a manual phone call to a hub, you have failed. The best executive forums healthcare discussions now center on how pharma can provide digital interfaces that integrate directly into the provider’s EHR or procurement software. If you aren't offering digital solutions that solve the "administrative load," your formulary position is at risk.
The Spreadsheet Methodology
I keep a running spreadsheet of every event I attend. It isn't a list of leads. It’s a list of "who I actually met and what they are worried about." If you attend a conference and walk away with a stack of business cards but no "Monday Morning Action Item," you failed the trip.
Contact Name/Title System Affiliation Primary Pain Point Monday Morning Action Item VP of Pharmacy, Large IDN Regional Health System Prior Auth burden on staff Send summary of our streamlined PA support portal. Chief Medical Officer Academic Medical Center HTA pricing uncertainty Connect with HEOR team for budget impact model.What Would You Do Differently on Monday?
After any conference or executive roundtable, I always force my team to answer: "What would I do differently on Monday?"
Usually, the answer is "stop emailing them until I have a specific solution to the problem they mentioned in the session." Executives have long memories. If you pitch them a product that isn't relevant to their system's specific financial pressures, they will remember you as "the rep who doesn't get it."
If you want time with them, stop trying to sell them. Start trying to solve their business problems. If you can help them navigate the HTA pressure or reduce the labor cost of managing their formulary, they will be the ones reaching out to you.
Executive Summary for Your Access Strategy
Differentiate your message: Clinical efficacy gets you in the conversation; financial impact keeps you in the room. Be present, but prepared: Use THMA and ACCC to listen, not to talk. Remove the "Cookie Law" friction: Your digital tools should make access easier, not harder. Execute on Monday: If you don't have a plan for the next business day, don't go to the conference.Stop looking for "networking." Start looking for problems you can fix. That is how you get your product on the formulary.